US Patent Number
5434185
Publication Date
7-18-1995
Abstract
Aurintricarboxylic acid has potent anti-angiogenic activity and may be used for new therapeutic approaches for diseases of neovascularization including the treatment of solid tumors, diabetic retinopathy and arthritis, among others.
Assignees
University of Kentucky Research Foundation, Lexington, Ky.
Application Number
61,477
Filing Date
05/17/1993
Recommended Citation
Collins, Delwood C.; Gagliardi, Antonio; and Bhattacharyya, Anjan, "Method for Inhibiting Angiogenesis with Aurintricarboxylic Acid, Its Analogues or Salts" (1995). Obstetrics and Genecology Faculty Patents. 1.
https://uknowledge.uky.edu/obgyn_patents/1
